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Hormesis refers to the beneficial effects of a treatment that at a higher intensity is harmful. In one form of
hormesis, sublethal exposure to stressors induces a response that results in stress resistance. The principle
of stress-response hormesis is increasingly finding application in studies of aging, where hormetic increases
in life span have been seen in several animal models.What Is Hormesis?
The term hormesis comes from the field of toxicology, and there
are several variants of its exact meaning. In its broadest (and
older) sense, it describes the dose-response relationships of
treatments (e.g., chemical, thermal, or radiological) that are ben-
eficial at a low level but harmful at a higher level (Figure 1) (for
a detailed review, see Calabrese et al., 1999). Beneficial effects
observed include increased growth rate, fecundity, and stress
resistance. Given the toxicological axiom ‘‘the dose determines
the poison,’’ this sort of dose-response relationship can apply to
agents that are not commonly considered toxic as well as those
that are. For example, oxygen sustains life at atmospheric levels
but is noxious at much higher levels.
However, there is a narrower sense in which hormesis is more
often understood in recent studies, which can be illustrated as
follows. Brief exposure to very high levels of oxygen can be ben-
eficial, for example, increasing life span in the nematode Caeno-
rhabditis elegans (Cypser and Johnson, 2002). Here, hormesis
appears to involve induction by stress of mechanisms that pro-
tect against stress. We shall refer to this form of hormesis as
‘‘stress-response hormesis’’ to distinguish it from hormesis in
the broader sense. The principle of stress-response hormesis
is nicely captured by the well-known maxim of the nineteenth-
century German philosopher Friedrich Nietzsche: ‘‘That which
does not kill us makes us stronger.’’
The principle of stress-response hormesis can be seen in
action in many contexts. As a classical example, low levels of in-
secticides can induce chemical resistance by increasing xenobi-
otic detoxification (Calabrese et al., 1999). Various other phe-
nomena involve stress-response hormesis, though they are not
typically described as such. For example, induction of drug-
metabolizing enzymes by xenobiotic chemicals can provide
protection against carcinogenesis (so-called chemoprotection)
(Talalay et al., 2003), and innate and acquired immunity involves
pathogen-stimulated resistance.
Hormesis: An Interesting History
Over the years, the concept of hormesis has been influential in
a number of unusual contexts, including quack medicine and
the popular imagination. Ideas about the benign effects of low
levels of toxins have their origins in the late nineteenth century
and the Arndt-Schulz ‘‘law,’’ which postulated that all poisons
are stimulatory in low doses. Proponents of homeopathy used200 Cell Metabolism 7, March 2008 ª2008 Elsevier Inc.this idea to justify their medical practice of administering com-
pounds at very low concentrations. It has been argued that its
association with homeopathy brought the concept of hormesis
into disrepute (Calabrese et al., 1999). More recently, controver-
sial claims about the health benefits of radiation hormesis were
rejected in a major review by the US National Research Council
(National Research Council, 2006).
Hormesis also has an unusual place in cinematic history. Dur-
ing the 1950s, reports on the capacity of ionizing radiation to
stimulate growth inspired the genre of so-called ‘‘nuclear mon-
ster’’ movies, which included Godzilla (1954) and Attack of the
50 Foot Woman (1958). Typical of this genre was Them! (1954),
in which ants exposed to radiation from atomic bomb tests
grow to gigantic proportions and terrorize residents of NewMex-
ico. (Contemporary publicity material promises ‘‘A horror hoard
of crawl-and-crush giants crawling out of the earth from mile-
deep catacombs!’’) Beyond this checkered past, the principle
of stress-response hormesis has found a new lease of life in
a novel context: the biology of aging.
Hormesis and Aging
From a molecular genetic perspective, stress-response horme-
sis corresponds to the induction by stressors of an adaptive,
defensive response, particularly through alteration of gene ex-
pression. For example, thermal stress induces a heat-shock
response involving increased expression of heat-shock proteins
(chaperonins). These lead to protection against heat-induced
molecular damage, particularly partial denaturation of proteins,
by promoting the restoration of protein function via molecular
chaperone activity.
The biological process of aging, while not fully understood, is
clearly associatedwithan increaseover time in levelsofmolecular
damage, which contributes to increasing pathology andmortality
at an organismal level. A powerful approach to investigating the
mechanisms underlying aging and controlling its rate is the use
of treatments that increase life span in laboratory model organ-
isms (e.g., the budding yeast Saccharomyces cerevisiae, C. ele-
gans, the fruit fly Drosophila melanogaster, and the mouse Mus
musculus). Such treatments include manipulations of the insu-
lin/IGF-1 signaling pathway and dietary restriction, the controlled
reduction of food intake without malnutrition (Kenyon, 2005).
Increased longevity can be associated with greater resistance
to a range of stressors. For example, long-lived C. elegans
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dative stress (Lithgow and Walker, 2002). One possibility is that
the increased longevity of these organisms is the result of
increased expression of genes contributing to cellular mainte-
nance processes, thereby protecting against themolecular dam-
age that causes aging. Consistent with this, C. elegans insulin/
IGF-1 signaling mutants show increased expression of a range
of heat-shock proteins and antioxidant and drug-metabolizing
enzymes (Lithgow and Walker, 2002; McElwee et al., 2007).
Whether induction of each of these classes of enzyme is suffi-
cient to increase life span remains largely undemonstrated.
However, overexpression of individual heat-shock proteins can
be sufficient to increase life span, at least in an insulin/IGF-1 sig-
naling mutant (Walker and Lithgow, 2003). Long-lived mutant
flies with reduced insulin/IGF-1 signaling also show some resis-
tance to oxidative stress (Clancy et al., 2001). However, flies that
are long lived as a result of dietary restriction do not show any
general increase in stress resistance (Burger et al., 2007). It is
therefore important to establish whether the stress resistance
associated with extension of life span by altered insulin/IGF-1
signaling is causal or simply correlated.
If induction of stress resistance increases life span and horm-
esis induces stress resistance, can hormesis result in increased
life span? Here the answer is definitively yes. For example, in
C. elegans, brief thermal stress sufficient to induce thermotoler-
ance also causes small but statistically significant increases in
life span (Lithgow et al., 1995). Significantly, the dose-response
relationships for thermotolerance and longevity are very similar
(Cypser and Johnson, 2002); furthermore, in C. elegans popula-
tions subjected tomild heat stress, expression levels of the small
heat-shock protein gene hsp-16 in individual worms are predic-
tive of both thermotolerance and life span (Wu et al., 2006).
These results further support the view that increased stress
resistance causes increased life span. Other sorts of stress-
response hormesis can also increase life span. For example,
brief exposure to hyperbaric oxygen or juglone (a compound
that generates reactive oxygen species) can increase life span
(Cypser and Johnson, 2002), perhaps through induction of anti-
oxidant enzymes, although this remains to be demonstrated. A
hypothetical view of the action of stress-response hormesis on
aging is shown in Figure 2.
Figure 1. Dose-Response Curve of a Treatment with a Hormetic
Effect
Low doses result in enhanced function, whereas higher doses result in dys-
function.This application of hormesis has implications for drug design,
opening the possibility of chemical inducers of hormesis (‘‘hor-
metins’’) with a range of therapeutic applications, including pro-
tection against aging-related disease. The animal model studies
described above also raise further questions, such as: What are
the processes that hormesis stimulates that increase life span?
Are all effects on aging attributable to induction of chaperonins,
or is induction of other biochemical processes important? Is se-
lective induction of expression of other maintenance processes
possible and sufficient to protect against aging? Other pro-
cesses that are candidate effectors in the impact of hormesis
on aging include antioxidant defense, biotransformation (xenobi-
otic metabolism), metal trafficking (e.g., metallothioneins and
ferritins), and innate immunity, all of which appear to be induced
in long-lived mutants.
Dietary Restriction, Insulin/IGF-1 Signaling,
and Hormesis
One possibility raised by studies of hormesis is that the increase
in life span in animals subjected to dietary restriction or in insulin/
IGF-1 signaling mutants results from hormesis. In fact, in each
case there is evidence consistent with this. For example, rats
subjected to dietary restriction show elevated plasma levels of
the stress hormone corticosterone relative to ad libitum-fed
controls and are resistant to carcinogenesis (e.g., phorbol es-
ter-induced skin papillomas). Whether the increased levels of
corticosteroids cause the increase in life span remains unclear.
However, it has been shown that if dietarily restricted rats are
adrenalectomized, their tumor resistance is abrogated (Masoro,
1998). These findings provide support for the possibility that
dietary restriction is a stressful condition and results in stress-re-
sponse hormesis and that this response contributes to increased
longevity (Masoro, 1998).
It has recently been suggested that extension of life span by
one type of dietary restriction, glucose restriction, in C. elegans
involves hormesis through an increase in mitochondrial respira-
tion and oxidative stress (Schulz et al., 2007). However, rodents
subjected to dietary restriction show lower levels of oxidative
damage and lower expression of oxidative defense systems
Figure 2. Possible Mechanism of Stress-Response Hormesis
Both stressors and aging causemolecular damage, leading to dysfunction and
death. Stressors can also induce a stress response leading to enhanced
somatic maintenance (e.g., via molecular chaperones and detoxification
enzymes) and resistance to stress. This response can also cause some resis-
tance to aging, suggesting that some overlap exists between the forms of
molecular damage that result from some types of stress and those occurring
during aging.Cell Metabolism 7, March 2008 ª2008 Elsevier Inc. 201
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dietary restriction may not be evolutionarily conserved.
Could hormesis be involved in the altered longevity of insulin/
IGF-1 signaling mutants? Hypothetically, abnormalities in insu-
lin/IGF-1 signaling could lead to a stressed metabolic state,
resulting in stress-response hormesis. The increase in life span
resulting from reduced insulin/IGF-1 signaling involves activation
of the FOXO transcription factor DAF-16 (Kenyon, 2005). Insulin/
IGF-1 receptor-activated kinases inactivate DAF-16 by phos-
phorylation, such that lowered insulin/IGF-1 signaling leads to
activation of DAF-16, which contributes to the increase in lon-
gevity. Mutation of the daf-16 gene fully suppresses the altered
longevity of insulin/IGF-1 signaling mutants, and mutation of
the daf-18 PTEN phosphatase also suppresses insulin/IGF-1
signaling-mediated increases in life span. Interestingly, exten-
sion of life span via hormesis, whether induced by heat or oxida-
tive stress, is suppressed by mutation of daf-16 or daf-18
(Cypser and Johnson, 2003). This is at least consistent with the
possibility that lowered insulin/IGF-1 signaling causes stress-re-
sponse hormesis, but further work will be required to determine
whether this is really true. Ultimately, this will require identifying
the genes and processes that are regulated by insulin/IGF-1
signaling that produce such large effects on aging rate and
establishing whether the same factors mediate the effects of
hormesis.
Here it is worth noting that the effects of dietary restriction on
C. elegans life span are, according to most studies, not daf-16
dependent, arguing that any role for hormesis in this context
must rely on different molecular mechanisms. Interestingly, in
Drosophila, extension of life span by altered insulin/IGF-1 signal-
ing, but not by dietary restriction, is associatedwith increased re-
sistance to bacterial infection, again arguing for different mech-
anisms (Libert et al., 2008). Possibly, the mechanisms by which
dietary restriction extends life span are different in different kinds
of organisms, with mammals showing a greater effect of horme-
sis. Alternatively, other types of hormesis may be important in
both rodents and the two invertebrates.
Hormesis and Biotransformation
The biotransformation system, the effector of drug/xenobiotic
metabolism, is very susceptible to hormetic induction. This is
a complex system of enzymes, including cytochrome P450 oxi-
dases and glutathione S-transferases, involved in both detoxifi-
cation and excretion of a wide range of biologically undesirable
organic compounds, including damaged cellular constituents,
drugs, and other environmental xenobiotics (Gibson and Skett,
2001). Induction of biotransformation provides protection
against molecular damage and can be achieved by administra-
tion of xenobiotics at nontoxic levels. This has been shown to
provide effective protection against molecular damage-induced
pathologies, including carcinogenesis and light-induced dam-
age in retinal epithelial cells (reviewed in Talalay et al., 2003).
This therapeutic, referred to as chemoprotection, is a form of
chemical stress-response hormesis.
One interesting possibility is that in long-lived animals (e.g.,
dietarily restricted animals or insulin/IGF-1 signaling mutants),
disturbances in physiology may cause internal chemical stress
that results in chemical hormesis of this type and increased life
span. A recent study of mice is consistent with this possibility.202 Cell Metabolism 7, March 2008 ª2008 Elsevier Inc.In recent years, a range of long-lived mutant mice have been
identified that have common abnormalities affecting growth hor-
mone (GH) and/or IGF-1 signaling. These include the Little
mouse, which has a defect in the GH-releasing hormone recep-
tor (Ghrhr) gene and is therefore GH deficient and, consequently,
a dwarf. Studies of hepatic gene expression in Little mice show
increased expression of biotransformation genes and imply
abnormalities in bile acid metabolism (Amador-Noguez et al.,
2007). Bile acids are oxidation products of cholesterol that con-
tribute to biliary function. These mice have been shown to be
resistant to xenobiotic toxicity, i.e., there is some correlation
between resistance to xenobiotic compounds and longevity.
Furthermore, induction of biotransformation proved to be attrib-
utable to increased levels of bile acids in this mutant, acting via
a nuclear hormone receptor, the farnesoid X receptor (FXR)
(Amador-Noguez et al., 2007). Thus, chemical hormesis leads
to induced biotransformation and xenobiotic resistance, al-
though the importance of this in longevity assurance remains
undemonstrated. Interestingly, long-lived insulin/IGF-1 signaling
mutant C. elegans and Drosophila also show evidence of ele-
vated expression of genes involved in xenobiotic metabolism
(McElwee et al., 2007).
Environmental Stressors: Good or Bad?
An intriguing implication of the study by Amador-Noguez et al.
(2007) relates to the role of bile acids in wild-type mice that, at
normal circulating levels, continually stimulate low-level expres-
sion of biotransformation genes via FXR. Thus, normal levels of
stressors may be important for setting the ‘‘tone’’ of the stress-
resistance processes. This is consistent with the broader view
that the best route to optimal health involves not the elimination
of all stressors from our environment but their reduction to opti-
mal levels. If true, this would have major implications for public
health policy.
Whether it is better to eliminate or optimize levels of an environ-
mental stressor will, of course, vary with the stressor concerned.
For example, elimination of ionizing radiation seems to be the
best course. Other stressors may have hormetic benefits that
are far outweighed by their dangers. An example here is cigarette
smoke, which is highly protective against Parkinson’s disease
(Quik, 2004). This is probably because nicotine has neurotrophic
effects but might also be because it induces biotransformation
enzymes that detoxify compounds that promote this disease.
For other stressors, a better course of action may be optimiza-
tion rather than elimination. Fruits and vegetables contain a wide
range of mildly stressful electrophilic compounds that stimulate
phase 2 xenobiotic metabolism and oxidative stress resistance
(Talalay et al., 2003). These include sulforaphane, an isothiocya-
nate isolated from broccoli, and resveratrol, a stilbene phyto-
alexin abundant in grape skins. The presence of such com-
pounds may contribute to the beneficial effects of eating fruits
and vegetables. In terms of immunity, the hygiene hypothesis
proposes that recent increases in the incidence of allergies and
asthma are due to insufficient exposure to pathogens during
childhood (Martinez, 2001). Tests of this hypothesis imply that ex-
posure tobacterial endotoxins in housedust is particularly impor-
tant. Similarly, the physiological stress of exercise has an optimal
point (e.g., for developingmuscle strength and improving cardio-
vascular health), beyond which detrimental effects can be
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tis). Another possible example here is alcohol consumption. Ep-
idemiological data show that, relative to abstainers, moderate
drinkers have reduced mortality risk, especially from coronary
heart disease (Marmot, 2001). However, it is not known whether
this effect involves stress-response hormesis.
In summary, the study of stress-response hormesis and the
induction by stressors of biochemical processes that protect
against stress is providing new insights into the mechanisms
that protect against a range of pathological processes, including
aging. It also suggests that improvements in public health may
be achieved through optimization of environmental stressors,
perhaps including dietary supplements to induce appropriate
forms of chemical hormesis.
ACKNOWLEDGMENTS
We thank the Wellcome Trust for support.
REFERENCES
Amador-Noguez, D., Dean, A., Huang,W., Setchell, K., Moore, D., andDarling-
ton, G. (2007). Aging Cell 6, 453–470.
Burger, J.M., Hwangbo, D.S., Corby-Harris, V., and Promislow, D.E. (2007).
Aging Cell 6, 63–71.
Calabrese, E.J., Baldwin, L.A., and Holland, C.D. (1999). Risk Anal. 19,
261–281.
Clancy, D.J., Gems, D., Harshman, L.G., Oldham, S., Hafen, E., Leevers, S.J.,
and Partridge, L. (2001). Science 292, 104–106.
Cypser, J.R., and Johnson, T.E. (2002). J. Gerontol. A Biol. Sci. Med. Sci. 57,
B109–B114.Cypser, J.R., and Johnson, T.E. (2003). Biogerontology 4, 203–214.
Gibson, G.G., and Skett, P. (2001). Introduction to Drug Metabolism, Third
Edition (Bath, UK: Nelson Thornes).
Kenyon, C. (2005). Cell 120, 449–460.
Libert, S., Chao, Y., Zwiener, J., and Pletcher, S.D. (2008). Mol. Immunol. 45,
810–817.
Lithgow, G.J., and Walker, G. (2002). Mech. Ageing Dev. 123, 765–771.
Lithgow, G.J., White, T.M., Melov, S., and Johnson, T.E. (1995). Proc. Natl.
Acad. Sci. USA 92, 7540–7544.
Marmot, M.G. (2001). Int. J. Epidemiol. 30, 724–729.
Martinez, F.D. (2001). Respir. Res. 2, 129–132.
Masoro, E.J. (1998). Exp. Gerontol. 33, 61–66.
McElwee, J.J., Schuster, E., Blanc, E., Piper, M.D., Thomas, J.H., Patel, D.S.,
Selman, C., Withers, D.J., Thornton, J.M., Partridge, L., and Gems, D. (2007).
Genome Biol. 8, R132.
National Research Council (2006). Health Risks from Exposure to Low Levels
of Ionizing Radiation: BEIR VII Phase 2 (Washington, DC: The National Acad-
emies Press).
Pamplona, R., and Barja, G. (2007). Ageing Res. Rev. 6, 189–210.
Quik, M. (2004). Trends Neurosci. 27, 561–568.
Schulz, T.J., Zarse, K., Voigt, A., Urban, N., Birringer, M., and Ristow, M.
(2007). Cell Metab. 6, 280–293.
Talalay, P., Dinkova-Kostova, A.T., and Holtzclaw, W.D. (2003). Adv. Enzyme
Regul. 43, 121–134.
Walker, G.A., and Lithgow, G.J. (2003). Aging Cell 2, 131–139.
Wu, D., Rea, S.L., Yashin, A.I., and Johnson, T.E. (2006). Exp. Gerontol. 41,
261–270.Cell Metabolism 7, March 2008 ª2008 Elsevier Inc. 203
